Microwave-assisted Click Generation of 1,2,3-Triazol Containing
Diphenylphosphine Oxides
November 2015
1881
13C-NMR (100.56 MHz, CDCl3) δ [ppm]: 149.8, 142.8, 139.1,
136.7, 133.5, 132.5, 131.9, 131.5, 130.9, 130.3, 124.1, 121.6,
21.5. MS (M+•; m/z): 374. IR (KBR) (vmax cmꢀ1): 2932 and
2853 (C–H), 1634 (C¼N), 1443 (C–N), 1381, 1233 (P¼O),
1020, 976 (P–O), 735 (P–C). Anal. Calcd. for C21H19N4OP: C,
67.37; H, 5.12, N, 14.97. Found: C, 67.29; H, 5.04; N, 14.88.
((1-(3-Nitropyridin-2-yl)-1H-1,2,3-triazol-4-yl)methyl)
diphenylphosphine oxide (6i). Yellow solid, mp: 166–168°C.
(C¼O) 1644 (C¼N), 1436 (C–N), 1228 (P¼O), 932 (P–O), 739
(P–C). Anal. Calcd. for C19H18N5O3P: C, 57.72; H, 4.59, N,
17.71. Found: C, 57.64 H, 4.50; N, 17.64.
((1-(Pent-4-en-1-yl)-1H-1,2,3-triazol-4-yl)methyl)
diphenylphosphine oxide (6n).
Pale yellow solid, mp: 147–
149°C. 31P-NMR (CDCl3) δ [ppm]: δ 24.13; 1H-NMR (400 MHz,
CDCl3) δ [ppm]: 7.46–7.18 (10H, m, Ar–H), 8.12 (1H, s,
2
N–CH¼), 6.13 (1H, m, C–CH¼), 5.45 (2H, d, JH-P = 6.54 Hz,
1
31P-NMR (CDCl3) δ [ppm]: 23.67; H-NMR (400 MHz, CDCl3)
P–CH2), 5.35–5.27 (2H, m, ¼CH2), 2.63–2.51 (2H, t, N–CH2),
1.50–1.44 (4H, m, –(CH2–)2); 13C-NMR (100.56 MHz, CDCl3) δ
[ppm]: 138.1, 136.4, 133.7, 132.5, 131.1, 131.1, 130.3, 124.1,
118.2, 54.2, 33.5, 27.2; MS (M+•; m/z): 351. IR IR (KBR)
(vmax cmꢀ1): 2931 and 2853 (C–H), 1635 (C¼N), 1441 (C–N),
1382, 1228 (P¼O), 1631 (C¼C), 1022, 974 (P–O), 733 (P–C).
Anal. Calcd. for C20H22N3OP: C, 68.36; H, 6.31, N, 11.96.
Found: C, 68.27; H, 6.24; N, 11.88.
δ [ppm]: 7.98–7.28 (13H, m, Ar–H), 8.36 (1H, s, N–CH¼), 5.53
2
(2H, d, JH-P = 6.54 Hz, P–CH2); 13C-NMR (100.56 MHz,
CDCl3) δ [ppm]: 155.4, 150.2, 144.9 136.0, 133.6, 133.2, 132.3,
131.7, 131.3, 130.3, 125.6, 124.4. MS (M+•; m/z): 405. IR
(KBR) (vmax cmꢀ1): 2932 and 2853 (C–H), 1630 (C¼N), 1547
(N¼O), 1443 (C–N), 1381, 1228 (P¼O), 1021, 971 (P–O), 732
(P–C). Anal. Calcd. for C20H16N5O3P: C, 59.26; H, 3.98, N,
17.28. Found: C, 59.19; H, 3.89; N, 17.20.
((1-Pentyl-1H-1,2,3-triazol-4-yl)methyl)diphenylphosphine
2-(4-((Diphenylphosphoryl)methyl)-1H-1,2,3-triazol-1-yl)
oxide (6o).
Pale yellow solid, mp: 142–144°C. 31P-NMR
nicotinonitrile (6j). Brown solid, mp: 171–173°C. 31P-NMR
(CDCl3) δ [ppm]: δ 24.33; 1H-NMR (400 MHz, CDCl3) δ [ppm]:
7.41–7.16 (10H, m, Ar–H), 8.22 (1H, s, N–CH¼), 5.42 (2H, d,
1
(CDCl3) δ [ppm]: 23.11; H-NMR (400 MHz, CDCl3) δ [ppm]:
3
7.98–7.28 (13H, m, Ar–H), 8.37 (1H, s, N–CH¼), 5.55 (2H, d,
2JH-P = 6.54 Hz, P–CH2); 13C-NMR (100.56 MHz, CDCl3) δ
[ppm]: 158.2, 153.6, 141.3, 135.9, 133.9, 133.1, 132.3, 131.7,
131.1, 130.5, 124.2, 117.8, 108.2. MS (M+•; m/z): 385. IR
(KBR) (vmax cmꢀ1): 2937 and 2856 (C–H), 2235 (C≡N), 1629
(C¼N), 1448 (C–N), 1385, 1235 (P¼O), 1020, 973 (P–O), 737
(P–C). Anal. Calcd. for C21H16N5OP: C, 65.45; H, 4.18, N,
18.17. Found: C, 65.37; H, 4.07; N, 18.09.
2JH-P = 6.54 Hz, P–CH2), 2.58 (2H, t, JH-H = 2.20 Hz, N–CH2),
3
1.50–1.41 (4H, m, –(CH2–)3), 1.79 (2H, t, JH-H = 6.51 Hz,
CH3); 13C-NMR (100.56 MHz, CDCl3) δ [ppm]: 135.9, 133.3,
132.3, 131.1, 131.1, 130.4, 124.9, 53.2, 30.8, 29.8, 23.5, 15.3.
MS (M+•; m/z): 353. IR (KBR) (vmax cmꢀ1): 2933 and 2854 (C–
H), 1637 (C¼N), 1444 (C–N), 1383, 1230 (P¼O), 1024, 972
(P–O), 735 (P–C). Anal. Calcd. for C20H24N3OP: C, 67.97; H,
6.85, N, 11.89. Found: C, 67.90; H, 6.76; N, 11.80.
((1-(4-Methylquinolin-2-yl)-1H-1,2,3-triazol-4-yl)methyl)
diphenylphosphine oxide (6k). Brown solid, mp: 176–178°C.
31P-NMR (CDCl3) δ [ppm]: 24.36; H-NMR (CDCl3) δ [ppm]:
1
Acknowledgements. We thank Prof. C. Devendranath Reddy,
Department of Chemistry, Sri Venkateswara University, Tirupati,
for his helpful discussions and Council of Scientific and Industrial
Research (CSIR), New Delhi, India for providing financial
assistance (S. No.: 02(0137)/13/EMR-II, dated 12-04-2013).
7.83–7.28 (15H, m, Ar–H), 8.26 (1H, s, N–CH¼), 5.55 (2H, d,
2JH-P = 6.54 Hz, P–CH2), 1.96 (3H, s, Ar–CH3); 13C-NMR
(100.56 MHz, CDCl3) δ [ppm]: 147.9, 146.8, 146.1, 135.5,
133.2, 132.3, 131.9, 131.5, 130.9, 130.4, 130.1, 127.1, 125.9,
125.5, 124.3, 113.5, 21.0. MS (M+•; m/z): 424. IR (KBR)
(vmax cmꢀ1): 2937 and 2855 (C–H), 1628 (C¼N), 1449 (C–N),
1378, 1236 (P¼O), 1027, 975 (P–O), 738 (P–C). Anal. Calcd.
for C25H21N4OP: C, 70.75; H, 4.99, N, 13.20. Found: C, 70.66;
H, 4.90; N, 13.12.
REFERENCES AND NOTES
[1] Sugawara, A.; Sunazuka, T.; Hirose, T.; Nagai, K.;
Yamaguchi, Y.; Hanaki, H.; Sharpless, K. B.; Omura, S. Bioorg Med
Chem Lett 2007, 17, 6340.
[2] Tron, G. C.; Pirali, T.; Billington, R. A.; Canonico, P. L.;
Sorba, G.; Genazzani, A. A. Med Res Rev 2008, 28, 278.
[3] Wacharasindhu, S.; Bardhan, S.; Wan, Z. K.; Tabei, K.;
Mansour, T. S. J Am Chem Soc 2009, 131, 4174.
[4] Hanselmann, R.; Job, G. E.; Johnson, G.; Lou, R. L.;
Martynow, J. G.; Reeve, M. M. Org Process Res Dev 2010, 14, 152.
[5] Mamidyala, S. K.; Finn, M. G. Chem Soc Rev 2010, 39, 1252.
[6] Boren, B. C.; Narayan, S.; Rasmussen, L. K.; Zhang, L.;
Zhao, H.; Lin, Z.; Jia, G.; Fokin, V. J Am Chem Soc 2008, 130, 8923.
[7] Steven, L.; Silvia, D.-G. J Org Chem 2011, 76, 2367.
[8] Huisgen, R. Helv Chim Acta 1967, 50, 2421.
((1-(8-Hydroxyquinolin-5-yl)-1H-1,2,3-triazol-4-yl)methyl)
diphenylphosphine oxide (6l). Brown solid, mp: 174–176°C.
31P-NMR (CDCl3) δ [ppm]: δ 23.93; 1H-NMR (400 MHz,
CDCl3) δ [ppm]: 7.89–7.18 (15H, m, Ar–H), 8.21 (1H, s,
2
N–CH¼), 5.51 (2H, d, JH-P = 6.54 Hz, P–CH2), 10.26 (1H, s,
Ar–OH); 13C-NMR (100.56 MHz, CDCl3) δ [ppm]: 156.5,
152.1, 139.6, 135.8, 133.8, 133.3, 132.5, 131.6, 131.2, 130.1,
127.6, 127.1, 124.5, 123.1, 118.9, 114.8. MS (M+•; m/z): 426.
IR (KBR), (vmax cmꢀ1): 3430 (OH), 2936 and 2859 (C–H), 1645
(C¼N), 1449 (C–N), 1385, 1226 (P¼O), 1021, 972 (P–O), 730
(P–C). Anal. Calcd. for C24H19N4O2P: C, 67.60; H, 4.49, N,
13.14. Found: C, 67.52; H, 4.41; N, 13.08.
5-(4-((Diphenylphosphoryl)methyl)-1H-1,2,3-triazol-1-yl)
dihydropyrimidine-2,4(1H,3H)-dione (6m). Brown solid, mp:
148–150°C. 31P-NMR (CDCl3) δ [ppm]: 24.59; 1H-NMR
(400 MHz, CDCl3) δ [ppm]: 9.92 (1H, s, CO–NH–CO), 8.22
(1H, s, C–NH–CO), 8.20 (1H, s, N–CH¼), 7.48–7.18 (10H, m,
N–CH), 2.70–2.55 (2H, m, N–CH2), 13C-NMR (100.56 MHz,
CDCl3) δ [ppm]: 178.5, 165.1, 135.7, 133.7, 132.6, 131.2,
131.5, 130.9, 124.2, 77.3, 42.3. MS (M+•; m/z): 395. IR (KBR)
(vmax cmꢀ1): 3341–3354 (NH), 2982 and 2863 (C–H), 1695–1710
[9] Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B.
Angew Chem Int Ed 2002, 41, 2596.
[10] Angell, Y. L.; Burgess, K. Chem Soc Rev 2007, 36, 1674.
[11] Fournier, D.; Hoogenboom, R.; Schubert, U. S. Chem Soc Rev
2007, 36, 1369.
[12] Moses, J. E.; Moorhouse, A. D. Chem Soc Rev 2007; 36; 1249.
[13] Radha Rani, C.; Ira, B.; Chandra Sekhar Reddy, G.; Syama
Sundar, Ch.; Suresh Reddy, C. Arch Pharm Chem Life Sci 2013, 346, 667.
[14] Chandra Sekhar Reddy, G.; Veeranarayana Reddy, M.;
Radha Rani, C.; Bakthavatchala Reddy, N.; Uma Maheswara Rao, K.;
Nayak, S. K.; Suresh Reddy, C. Heteroatom Chem 2012, 23, 247.
2
Ar–H), 5.50 (2H, d, JH-P = 6.54 Hz, P–CH2), 3.44–3.37 (1H, m,
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet